liraglutide vs tirzepatide weight loss semaglutide and for in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Comparing Tirzepatide and Liraglutide for

J Clin Endocrinol Metab (2007) 92(12):45635.10.1210/jc.2007-2260 21 SalehiMVellaAMcLaughlinTPattiME

Cervantes A, Waymouth EK, Petrov MS

Many participants lost an average percentage of their body weight similar to early-stage GLP-1 injection trials, which is why experts believe it may emerge as a major rival to injectable GLP-1 receptor agonists

Some research protocols explore stacking with melatonin, magnesium, or GABA-related compounds, but this raises the risk of excessive sedation

Rotate with every dose: DailyMed label requires rotating injection sites each weekly injection Avoid damaged skin: Do not inject into tender, bruised, damaged, or scarred skin within any approved zone Investigational status: Retatrutide has no FDA-approved IFU yet